Documentos relacionados

1. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
2. Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis.
3. A Case of Intravenous IVIg Interfering with Serological Test Results of HBV.
4. Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
5. Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response.
6. Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.
7. Intravenous immunoglobulins ameliorate thrombin-related platelet functions in childhood immune thrombocytopenia.
8. IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia.
9. Why should intramuscular anti-D be different from intravenous anti-D?
10. Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia.